Third-Generation Bruton tyrosine kinase Inhibitors for the Treatment of Monoclonal Gammopathy of Thrombotic Significance (MGTS).

ABSTRACT:

SUBMITTER: Man L 

PROVIDER: S-EPMC12743631 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature